Abstract
Carcinogen detoxifying genes may be involved in pathogenesis of head and neck cancer (HNC). CYP1A1 is phase I enzyme that converts carcinogens into water soluble compounds which are easily excreted from body. GSTs constitute phase II detoxification enzymes that recognize these highly electrophilic compounds and detoxify them. Abnormal expression of these genes can potentially lead to cancer initiation. In present study, we analyzed protein expression of these genes in a total of 192 HNC patients and noncancerous healthy control serum samples screened for GSTs specific activity by ELISA. Furthermore, expression of these molecules was also determined in 49 HNC tissues/ adjacent control tissue by immunohistochemistry with specific antibodies. Mean serum GSTs specific activity was found to be 7.7 (+11.5)U/L in HNC patients and 11.4 (+7.5)U/L in controls. Significant decrease (P < 0.05) in GSTs specific activity was observed in HNC patients compared with controls (P < 0.001). Data for immunohistochemistry showed that CYP1A1 and GSTT1 was down expressed whereas GSTP1 was over expressed in HNC tissues compared with adjacent normal control tissues. Results of immunohistochemistry revealed 63 % HNC tissues had weak, 27 % moderate and 10 % strong staining for CYP1A1. For GSTT1, 27 % HNC tissues had no staining, 49 % weak staining, 16 % moderate and 8 % strong staining. Similarly for GSTP1, percentages for weak, moderate and strong staining were 6 %, 12 % and 82 % respectively. These reduced proteins observed in cancer patients highlight a potential breach on DNA repair mechanism when compared with control. Thus altered expression of these detoxifying molecules may collectively contribute to HNC development in Pakistani population.
Similar content being viewed by others
References
Bhurgri Y (2005) Cancer of the oral cavity- trends in Karachi south (1995–2002). Asian Pac J Cancer Prev 6(1):22–26
Toru H, Masaharu Y, Shinji T, Kazuaki C (2008) Genetic polymorphisms and head and neck cancer risk. Int J Oncol 32(5):945–973
Hanif M, Zaidi P, Kamal S, Hameed A (2009) Institution based cancer incidence in a local population in Pakistan: nine year data analysis. Asian Pac J Cancer Prev 10(2):227–230
Guengerich FP, Simada T (1991) Oxidation of toxic and carcinogenic chemicals by human cytochrome P 450 enzymes. Chem Res Toxicol 4:341–407
Masood N, Kayani MA (2011) Mutational analysis of xenobiotic metabolizing genes (CYP1A1 and GSTP1) in sporadic head and neck cancer patients. Genet Mol Biol 34(4):533–538
Masood N, Kayani MA, Malik FA, Ishrat M, Baig RM, Faryal R (2011) Genetic variations in carcinogen metabolizing genes associated with oral cancer in Pakistani population. Asian Pac J Cancer Prev 12:491–495
Masood N, Malik FA, Ishrat M, Baig RM, Kayani MA (2011) A novel CYP1A1 gene polymorphism and the risk of head and neck cancer in Pakistani population. Afr J Biotechnol 10(27):5273–5280
Masood N, Ishrat M, Malik FA, Baig RM, Kayani MA (2010) Association of GSTM1 and GSTT1 gene deletions with risk of head and neck cancer in Pakistan: a case control study. Asian Pac J Cancer Prev 11:881–885
Masood N, Malik FA, Kayani MA (2011) Expression of xenobiotic metabolizing genes in head and neck cancer tissues. Asian Pac J Cancer Prev 12(2):377–382
Farin FM, Bigler LG, Oda D, McDougall JK, Omiecinski CJ (1995) Expression of cytochrome P450 and microsomal exposide hydrolase in cervical and oral epithelial cells immortalized by human papillomavirus type 16 E6/E7 genes. Carcinogenesis 16:1670
Tu CP, Weiss MJ, Li NQ, Reddy CC (1983) Tissue-specific expression of the rat glutathione S-transferases. J Biol Chem 8:4659–4662
Hayes JD, Pulford DJ (1995) The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30(6):445–600
Tsuchida S (1990) Purification and characterization of glutathione transferases with an activity toward nitroglycerin from human aorta and heart: multiplicity of the human class mu forms. J Biol Chem 13:7150–7157
Matthias C, Jahnke V, Hand P et al (1999) Immunhistologische und molekular genetische untersuchungen des effektes der glutathion-S-transferase auf die entstehung von plattenepithelkarzinomen der Kopf-Hals-region ([immunohistologic and molecular genetic studies of the effect of glutathione-S-transferases on the development of squamous epithelial carcinomas in the area of the head-neck]). Laryngorhinootologie 78:182–188
Matthias C, Bockmuhl U, Jahnke V et al (1998) The glutathione S-transferase GSTP1 polymorphism: effects on susceptibility to oral/pharyngeal and laryngeal carcinomas. Pharmacogenetics 8(1):1–6
Niitsu Y, Takahashi Y, Saito T, Hirata Y, Arisato N, Maruyama H, Kohgo Y, Listowsky I (1989) Serum glutathione-S-transferase-pi as a tumor marker for gastrointestinal malignancies. Cancer 63(2):317–323
Seidegard J, Pero RW, Miller DG et al (1986) A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer. Carcinogenesis 7(5):751–753
Lafuente A, Pujol F, Carretero P et al (1993) Human glutathione S-transferase mu (GST mu) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers. Cancer Lett 68(1):49–54
Lafuente A, Molina R, Palou J et al (1995) Phenotype of glutathione S-transferase mu (GSTM1) and susceptibility to malignant melanoma: MMM (multidisciplinary malignant melanoma) group. Br J Cancer 72(2):324–326
Patel BP, Raval GN, Rawal RM, Patel JB, Sainger RN, Patel MM, Shah MH, Patel DD, Patel PS (2002) Serum glutathione-S-transferase and glutathione reductase activity in head and neck cancer patients. Neoplasma 49(4):260–266
Ferruzzi E, Franceschini R, Cazzolato G, Geroni C, Fowst C, Pastorino U, Tradati N, Tursi J, Dittadi R, Gion M (2003) Blood glutathione as a surrogate marker of cancer tissue glutathione S-transferase activity in non-small cell lung cancer and squamous cell carcinoma of the head and neck. Eur J Cancer 39(7):1019–1029
Van Der Zee AGJ, Van Ommen B, Meijer C, Hollema H, Van Bladeren PJ (1992) Glutathione S-transferase activity and isoenzyme composition in benign ovarian tumors, untreated malignant ovarian tumors, and malignant ovarian tumors after platinum/Cyclophosphamide chemotherapy. Br J Cancer 66:930–936
Sprem M, Babic D, Abramic M et al (2001) Glutathione and glutathione S-transferase as early markers for ovarian carcinomas: case series. Croat Med J 42(6):624–629
Smart J, Daly AK (2000) Variation in induced CYP1A1 levels: relationship to CYP1A1, Ah receptor and GSTM1 polymorphisms. Pharmacogenetics 10:11–24
Anttila S, Tuominen P, Hirvonen A et al (2001) CYP1A1 levels in lung tissue of tobacco smokers and polymorphisms of CYP1A1 and aromatic hydrocarbon receptor. Pharmacogenetics 11:501–509
Wandel C, Witte JS, Hall JM, Stein CM, Wood AJ, Wilkinson GR (2000) CYP3A activity in African American and European American men: population differences and functional effect of the CYP3A4*1B5′- promoter region polymorphism. Clin Pharmacol Ther 68:82–91
El-Rayes BF, Ali S, Heilbrun LK et al (2003) Cytochrome p450 and glutathione transferase expression in human breast cancer. Clin Cancer Res 9:1705–1709
Murray GI, Shaw D, Weaver RJ, McKay JA, Ewen SW, Melvin WT, Burke MD (1994) Cytochrome P450 expression in oesophageal cancer. Gut 35:599–603
Murray GI, Taylor VE, McKay JA, Weaver RJ, Ewen SW, Melvin WT, Burke MD (1995) Expression of xenobiotic metabolizing enzymes in tumors of the urinary bladder. Int J Exp Pathol 76:271–276
Theo PJ, Johannes JM, Hennie MJ, Wilbert HM, Anne W (1995) Glutathione S transferases and glutathione in human head and neck cancer. Carcinogenesis 16(3):619–624
David GB, Isabelle M, Jonathan H (2007) Glutathione S transferase: differential expression of alpha, mu and pi isoenzymes in benign prostate, prostatic intraepithelial neoplasia, and prostatic adenocarcinoma. Hum Pathol 38:1394–1401
Ioanna AD, Demetrios AA, Demetrios AS (2001) Genetic polymorphisms and transcriptional pattern analysis of CYP1A1, AhR, GSTM1, GSTP1 and GSTT1 genes in breast cancer. Int J Mol Med 8:79–87
Tanita J, Tsuchida S, Hozawa J, Sato K (1993) Expression of glutathione S-transferase-pi in human squamous cell carcinomas of the pharynx and larynx. Loss after radiation therapy. Cancer 72:569–576
Chen YK, Lin LM (1995) Immunohistochemical demonstration of epithelial glutathione S-transferase isoenzymes in normal, benign, premalignant and malignant human oral mucosa. J Oral Pathol Med 24:316–321
Bentz BG, Haines GK, Radosevich JA (2000) Glutathione S-transferase pi in squamous cell carcinoma of the head and neck. Laryngoscope 110:1642–1647
Mulder TPJ, Manni JJ, Roelofs HMJ, Peters WHM, Wiersma A (1995) Glutathione S-transferases and glutathione in human head and neck cancer. Carcinogenesis 16:619–624
Anna Y, Russell V, Malti K, Dan L, Morgan AM, Ie M, Robert JK (2011) Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis. Mod Pathol 24:1248–1253
Acknowledgment
Authors would like to thank all the participants of this study. Special thanks to COMSATS Institute of Information Technology, Islamabad, Pakistan and Higher Education Commission Pakistan for financial assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Masood, N., Kayani, M.A. Expression Patterns of Carcinogen Detoxifying Genes (CYP1A1, GSTP1 & GSTT1) in HNC Patients. Pathol. Oncol. Res. 19, 89–94 (2013). https://doi.org/10.1007/s12253-012-9563-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12253-012-9563-3